These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19149663)

  • 21. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
    Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
    Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives.
    Takahashi D; Oyunzul L; Onoue S; Ito Y; Uchida S; Simsek R; Gunduz MG; Safak C; Yamada S
    Biol Pharm Bull; 2008 Mar; 31(3):473-9. PubMed ID: 18310913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity.
    Dietz JD; Du S; Bolten CW; Payne MA; Xia C; Blinn JR; Funder JW; Hu X
    Hypertension; 2008 Mar; 51(3):742-8. PubMed ID: 18250364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fused 1,4-dihydropyridines as potential calcium modulatory compounds.
    Safak C; Simsek R
    Mini Rev Med Chem; 2006 Jul; 6(7):747-55. PubMed ID: 16842124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of thyroid hormone uptake by calcium antagonists of the dihydropyridine class.
    Scholz GH; Vieweg S; Uhlig M; Thormann M; Klossek P; Goldmann S; Hofmann HJ
    J Med Chem; 1997 May; 40(10):1530-8. PubMed ID: 9154974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs.
    Ioan P; Carosati E; Micucci M; Cruciani G; Broccatelli F; Zhorov BS; Chiarini A; Budriesi R
    Curr Med Chem; 2011; 18(32):4901-22. PubMed ID: 22050742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,4-Dihydropyridines as calcium channel ligands and privileged structures.
    Triggle DJ
    Cell Mol Neurobiol; 2003 Jun; 23(3):293-303. PubMed ID: 12825828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
    Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
    Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
    Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMILES-based QSAR models for the calcium channel-antagonistic effect of 1,4-dihydropyridines.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Arch Pharm (Weinheim); 2013 Feb; 346(2):134-9. PubMed ID: 23280520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Condensed 1,4-dihydropyridines with various esters and their calcium channel antagonist activities.
    Bülbül B; Oztürk GS; Vural M; Simşek R; Sarioğlu Y; Linden A; Ulgen M; Safak C
    Eur J Med Chem; 2009 May; 44(5):2052-8. PubMed ID: 19013690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coumarin 1,4-dihydropyridine derivatives.
    Valenti P; Rampa A; Budriesi R; Bisi A; Chiarini A
    Bioorg Med Chem; 1998 Jun; 6(6):803-10. PubMed ID: 9681146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the absolute configuration of biologically active (S)-(-)-NB 818 and its structural correlation with the stereoselectivity of the channel blocking action.
    Yamazaki Y; Ebiike H; Achiwa K
    Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1968-70. PubMed ID: 7954946
    [No Abstract]   [Full Text] [Related]  

  • 36. Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.
    Arhancet GB; Woodard SS; Dietz JD; Garland DJ; Wagner GM; Iyanar K; Collins JT; Blinn JR; Numann RE; Hu X; Huang HC
    J Med Chem; 2010 May; 53(10):4300-4. PubMed ID: 20408553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GA strategy for variable selection in QSAR studies: GA-based PLS analysis of calcium channel antagonists.
    Hasegawa K; Miyashita Y; Funatsu K
    J Chem Inf Comput Sci; 1997; 37(2):306-10. PubMed ID: 9157101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative structure-activity relationship studies on some series of calcium channel blockers.
    Gupta SP; Veerman A; Bagaria P
    Mol Divers; 2004; 8(4):357-63. PubMed ID: 15612639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of calcium channel blockers are not related to their chemical structure in the collar model of the rabbit.
    Yasa M; Kerry Z; Reel B; Yetik Anacak G; Ertuna E; Ozer A
    J Int Med Res; 2007; 35(1):59-71. PubMed ID: 17408056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The learned symmetry concept in revealing quantitative structure-activity relationships with artificial neural networks.
    Baskin II; Halberstam NM; Mukhina TV; Palyulin VA; Zefirov NS
    SAR QSAR Environ Res; 2001; 12(4):401-16. PubMed ID: 11769122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.